Virinchi Limited has informed the Exchange regarding allotment of 1315715 securities pursuant to Preferential Issue at its meeting held on February 24, 2026

Warrants ConvertedQip At PremiumFund Raising View source PDF Explain this filing

VIRINCHI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.8%Reaction day

₹19.95

prior close

₹19.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-1.5% vs market

Software Products peers, median of 34sector-1.9%-1.0% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.0 pts less than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.5

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.8-1.3-1.5-1.9-1.0

Next day

-4.3-1.1-3.2-2.6-1.6

-2.3-0.8-1.4-3.3+1.1

-1.3-1.9+0.6-2.1+0.8

-4.5-4.1-0.4-4.2-0.2

-5.9-6.6+0.7-5.3-0.6

-0.3-5.7+5.5-1.3+1.1

15d

-16.1-6.4-9.8-4.5-11.7

-21.9-9.9-11.9-9.9-12.0

-9.8+3.8-13.6-1.8-7.9

-15.6+8.9-24.4-6.6-9.0

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 34Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Virinchi Limited has allotted 13,15,715 equity shares of Rs. 10 each at an issue price of Rs. 28 per share (a premium of Rs. 18) following the conversion of warrants that were earlier issued on a preferential basis. The shares have been allotted entirely to Vivo Bio Tech Limited, a member of the company's Promoter Group, against receipt of Rs. 2.76 crore being 75% of the total consideration. As a result, the company's issued and subscribed share capital has risen to Rs. 108.80 crore, comprising 10,87,96,896 equity shares of Rs. 10 each.

Likely market impact

This is a promoter-group led equity infusion at a premium to face value, which strengthens the capital base and signals continued promoter confidence, though it also results in equity dilution for existing shareholders. The stock may see a mildly negative technical impact in the short term due to the increase in share count.